Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization DOI
Laura Elst,

Gino Philips,

Kaat Vandermaesen

et al.

European Urology, Journal Year: 2024, Volume and Issue: 86(2), P. 114 - 127

Published: April 26, 2024

Language: Английский

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth DOI Creative Commons
Karin E. de Visser, Johanna A. Joyce

Cancer Cell, Journal Year: 2023, Volume and Issue: 41(3), P. 374 - 403

Published: March 1, 2023

Language: Английский

Citations

1658

Biology and therapeutic targeting of vascular endothelial growth factor A DOI
Lorena Pérez, Napoleone Ferrara

Nature Reviews Molecular Cell Biology, Journal Year: 2023, Volume and Issue: 24(11), P. 816 - 834

Published: July 25, 2023

Language: Английский

Citations

195

Mucosal immune responses to infection and vaccination in the respiratory tract DOI Creative Commons
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas

et al.

Immunity, Journal Year: 2022, Volume and Issue: 55(5), P. 749 - 780

Published: May 1, 2022

Language: Английский

Citations

156

Understanding tumour endothelial cell heterogeneity and function from single-cell omics DOI
Qun Zeng, Mira Mousa,

Aisha Shigna Nadukkandy

et al.

Nature reviews. Cancer, Journal Year: 2023, Volume and Issue: 23(8), P. 544 - 564

Published: June 22, 2023

Language: Английский

Citations

94

Controlling the biodistribution and clearance of nanomedicines DOI
Horacio Cabral, Junjie Li, Kanjiro Miyata

et al.

Nature Reviews Bioengineering, Journal Year: 2023, Volume and Issue: 2(3), P. 214 - 232

Published: Dec. 20, 2023

Language: Английский

Citations

88

Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast DOI Creative Commons
Vincent Geldhof, Laura de Rooij, Liliana Sokol

et al.

Nature Communications, Journal Year: 2022, Volume and Issue: 13(1)

Published: Sept. 20, 2022

Abstract Since a detailed inventory of endothelial cell (EC) heterogeneity in breast cancer (BC) is lacking, here we perform single RNA-sequencing 26,515 cells (including 8433 ECs) from 9 BC patients and compare them to published EC taxonomies lung tumors. Angiogenic ECs are phenotypically similar, while other subtypes different. Predictive interactome analysis reveals known but also previously unreported receptor-ligand interactions between immune cells, suggesting an involvement responses. We identify capillary subtype (LIPEC (Lipid Processing EC)), which expresses genes involved lipid processing that regulated by PPAR-γ more abundant peri-tumoral tissue. Retrospective 4648 treatment with metformin (an indirect signaling activator) provides long-lasting clinical benefit positively associated LIPEC abundance. Our findings warrant further exploration this LIPEC/PPAR-γ link for treatment.

Language: Английский

Citations

81

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma DOI Open Access
Francesco Lasorsa,

Monica Rutigliano,

Martina Milella

et al.

Journal of Clinical Medicine, Journal Year: 2023, Volume and Issue: 12(12), P. 3888 - 3888

Published: June 7, 2023

Globally, clear-cell renal cell carcinoma (ccRCC) represents the most prevalent type of kidney cancer. Surgery plays a key role in treatment this cancer, although one third patients are diagnosed with metastatic ccRCC and about 25% will develop recurrence after nephrectomy curative intent. Molecular-target-based agents, such as tyrosine kinase inhibitors (TKIs) immune checkpoint (ICIs), recommended for advanced cancers. In addition to cancer cells, tumor microenvironment (TME) includes non-malignant types embedded an altered extracellular matrix (ECM). The evidence confirms that interactions among cells TME elements exist thought play crucial roles development making them promising therapeutic targets. TME, unfavorable pH, waste product accumulation, competition nutrients between may be regarded further possible mechanisms escape. To enhance immunotherapies reduce resistance, it is first understand how work interact other cancer-associated complex microenvironment.

Language: Английский

Citations

71

Immunomodulatory biomaterials against bacterial infections: Progress, challenges, and future perspectives DOI Creative Commons
Shutao Zhang, Hongtao Yang, Minqi Wang

et al.

The Innovation, Journal Year: 2023, Volume and Issue: 4(6), P. 100503 - 100503

Published: Aug. 29, 2023

•Insights into the intricate facets of immune microenvironment hold key to pioneering clinical strategies in combatting bacterial infections.•The design principles for antimicrobial biomaterials vary depending on at different stages infection.•Immunomodulatory display robust efficacy and vaccine attributes animals trials, promising intractable infections. Bacterial infectious diseases are one leading causes death worldwide. Even with use multiple antibiotic treatment strategies, 4.95 million people died from drug-resistant infections 2019. By 2050, number deaths will reach 10 annually. The increasing mortality may be partly due heterogeneity infection microenvironment, such as bacteria, biofilms, persister cells, intracellular small colony variants. In addition, complexity makes direct activity unsatisfactory long-term chronic attributed failing modulate active action cells. Therefore, there is an urgent need effective alternatives treat Accordingly, development immunomodulatory has recently received considerable interest; however, a comprehensive review their research progress lacking. this review, we focus mainly future perspectives used infection. First, describe characteristics acute phases Then, highlight corresponding advantages disadvantages. Moreover, discuss biomaterial-mediated vaccines' potential applications challenges activating innate adaptive memory. This serve reference studies develop next-generation accelerate translation practice.

Language: Английский

Citations

65

Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis DOI Creative Commons
Min Wang, Jun Feng,

Daixing Zhou

et al.

European journal of medical research, Journal Year: 2023, Volume and Issue: 28(1)

Published: Sept. 12, 2023

Abstract Background Lipopolysaccharide, a highly potent endotoxin responsible for severe sepsis, is the major constituent of outer membrane gram-negative bacteria. Endothelial cells participate in both innate and adaptive immune responses as first cell types to detect lipopolysaccharide or other foreign debris bloodstream. are able recognize presence LPS recruit specific adaptor proteins domains TLR4, thereby initiating an intracellular signaling cascade. However, binding endothelial induces activation even damage, manifested by expression proinflammatory cytokines adhesion molecules that lead sepsis. Main findings involved local systemic inflammation, activating immunity. Translocation into circulation causes endotoxemia. dysfunction, including exaggerated coagulopathy vascular leakage, may play central role dysregulated host response pathogenesis By discussing many strategies used treat this review attempts provide overview how ever more complex syndrome sepsis potential development novel therapeutics. Conclusions To reduce patient morbidity mortality, preservation function would be management Graphical

Language: Английский

Citations

46

The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity DOI
Ibrahim AlZaim, Laura de Rooij, Bilal N. Sheikh

et al.

Nature Reviews Endocrinology, Journal Year: 2023, Volume and Issue: 19(12), P. 691 - 707

Published: Sept. 25, 2023

Language: Английский

Citations

43